All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a Q1 report for Amicus Therapeutics, Inc. on April 18, 2026, reporting $30,000 in lobbying income.

Lobbying for Amicus Therapeutics, Inc. · Biopharmaceutical company.

As filed: CAPITOL COUNSEL LLC for AMICUS THERAPEUTICS, INC.

All filings by Capitol Counsel LLC · Everything Amicus Therapeutics, Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 18, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 2

KAREN STONE New on this filing

Previously held: Legislative Director, Rep. Dina Titus (D-NV); Legislative Correspondent/Staff Assistant, Rep. Steve Israel (D-NY); Senior Legislative Assistant, Rep. Steve Israel (D-NY).
CHARLES PATRICK MICHAELS New on this filing

Previously held: Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Legislative and regulatory issues affecting SMID rare disease biotech companies. FDA approvals of rare diseases.

Medicare/Medicaid

Legislative and regulatory issues affecting SMID rare disease biotech companies.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.